Why You Can't Sleep on Peptides

Your body has one job while you sleep: keep your blood glucose stable enough that your brain keeps running without sending out an emergency signal.

When that system works, you sleep through the night without waking up. When it fails, your adrenal glands release cortisol and adrenaline to drive glucose back up, and that hormonal surge is enough to pull you out of deep sleep at two or three in the morning with your heart beating faster than it should. You're not experiencing insomnia. You're experiencing a metabolic rescue response.

That's the whole chain. And if you started a peptide protocol recently and your sleep fell apart, that chain is almost certainly where the problem lives.

To understand why, you need to understand what happens to blood sugar regulation during the night normally. Your liver is running something called gluconeogenesis, which is the process of manufacturing glucose from non-carbohydrate sources like amino acids and glycerol, so your brain has a steady fuel supply between meals. This process is controlled in part by insulin, which acts like a brake on glucose production, and by several counter-regulatory hormones, including growth hormone, cortisol, and glucagon, which act like a gas pedal. Under normal conditions these systems balance. The brake and the gas pedal work together and blood glucose stays in a narrow range all night.

Peptides can knock that balance off in two completely different ways depending on which class you're taking.

The first class is something called GLP-1 receptor agonists and related incretins, which includes compounds like semaglutide, tirzepatide, and retatrutide. These drugs work by mimicking gut hormones that signal fullness and regulate appetite. The appetite suppression is real and it's strong. In the phase 2 trial for retatrutide, participants at the 12mg dose lost an average of 24.2% of their body weight over 48 weeks, which is a number that requires sustained, significant caloric reduction to produce. The mechanism isn't willpower. The drug is changing hunger signaling at the level of the brain, and most people on these compounds report that food simply stops being appealing in a way that's hard to override.

The problem that creates at night is that less food during the day means less stored fuel going into sleep. Your liver's glycogen stores, which are the first line of defense for overnight glucose maintenance, are smaller than they would be if you had eaten normally. So gluconeogenesis has to carry more of the load, and if total caloric intake has dropped far enough, the system runs short before morning.

The second class creates the problem from the opposite direction. Compounds like CJC-1295, ipamorelin, and tesamorelin are something called growth hormone secretagogues, which are peptides that stimulate the pituitary gland to release pulses of growth hormone. These are typically injected before bed because that timing aligns with the body's natural GH release, which peaks in the first few hours of sleep.

Growth hormone is directly anti-insulin. This is not a side effect, it's a primary mechanism. Research published in Endocrine Reviews describing GH's metabolic effects shows that GH drives free fatty acid release from fat tissue, and those free fatty acids are taken up preferentially by muscle and liver cells, which then reduces their sensitivity to insulin. When insulin's effectiveness drops, the liver reads that as a signal to produce more glucose. The brake has been released and the gas pedal is still running.

The clearest demonstration of this mechanism comes from research on what diabetologists call the dawn phenomenon. When researchers suppressed nocturnal growth hormone spikes using somatostatin, the early-morning glucose rise disappeared. When they artificially restored those GH spikes, the effect came back, and hepatic glucose production increased by approximately 30%. That single intervention, restoring a GH pulse, produced a 30% increase in liver glucose output. That's how much leverage GH has over overnight glucose dynamics.

Now if you're on both a GH secretagogue and an incretin, both mechanisms are running at once. The incretin has reduced how much fuel you stored going into the night. The GH pulse is simultaneously reducing insulin sensitivity and driving the liver to overproduce glucose. The result can be exaggerated swings in both directions, and every time glucose drops below a threshold your hypothalamus recognizes as dangerous, the cortisol alarm goes off.

The fix follows directly from the mechanism.

If the problem is undereating on an incretin, the answer is making sure total caloric intake during the day is adequate even when you're not hungry. The drug is suppressing hunger signals, but your overnight metabolic requirements didn't change. If you are following a low carb or ketogenic approach, that specific pattern isn't the issue as long as total calories are sufficient, because a fat-adapted metabolism runs gluconeogenesis more efficiently and your brain becomes capable of using ketones as an alternative fuel. The problem is when the drug drops intake so low that both glucose stores and ketone production are insufficient.

If the problem is GH-driven insulin antagonism from a bedtime injection, moving the injection two to three hours earlier before sleep gives the initial GH pulse more time to clear before your deepest sleep stages, which reduces the magnitude of the overnight glucose swing. A small snack containing protein and fat before bed also helps, because protein provides gluconeogenic substrate and fat slows gastric emptying, which together extend the rate at which your body can manufacture and release glucose slowly enough to avoid both the crash and the overcorrection.

The reason this matters beyond just sleep quality is that the cortisol spike is doing other things at the same time it's waking you up. Cortisol further increases insulin resistance, suppresses immune function, and blunts the recovery processes that sleep itself is supposed to support. If you're using peptides for body composition, performance, or recovery, repeatedly triggering that adrenal response at night is working against every other goal you're trying to achieve.

The sleep disruption is not a sign that peptides don't work. It's the opposite. It's the clearest possible sign that the compounds are doing exactly what they're designed to do, and your nutrition and timing haven't caught up yet.

---

References

1. Perriello G, De Feo P, Torlone E, et al. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 diabetes mellitus by decreasing hepatic and extrahepatic sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990;331:52-59. Finding: Suppressing nocturnal GH spikes with somatostatin abolished the dawn phenomenon; restoring GH spikes reproduced it. Hepatic glucose production increased approximately 30%. Source
2. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009;302:152-177. Finding: GH antagonizes insulin's hepatic and peripheral effects via increased free fatty acid flux and uptake. Source
3. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. New England Journal of Medicine. 2023;3896:514-526. Finding: 24.2% mean weight loss at 12mg dose; significant appetite suppression documented across all dose groups. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness